CROSS SPECIES SINGLE DOMAIN ANTIBODIES TARGETING PD-L1 FOR TREATING SOLID TUMORS Application WO-2022261017-A1 World Intellectual Property Organisation (WIPO) 15 Dec 2022
CHIMERIC ANTIGEN RECEPTOR BINDING SPECIFICALLY TO PROGRAMMED DEATH-LIGAND 1 (PD-L1) AND… Application WO-2022220433-A1 World Intellectual Property Organisation (WIPO) 20 Oct 2022
CHIMERIC TARGET FACTOR RECEPTOR Application WO-2022153698-A1 World Intellectual Property Organisation (WIPO) 21 Jul 2022
PD-L1-SPECIFIC ANTIBODY AND ANTI-PD-L1-CAR-T CELLS Application WO-2021262499-A1 World Intellectual Property Organisation (WIPO) 30 Dec 2021